Healthcare -
Biotechnology - NASDAQ - US
$ 0.5265
-0.66 %
$ 37.4 M
Market Cap
-1.14
P/E
Price Target
Average
1292.85%
Revenue Forecast
Estimate
280.58%
EBIT
Estimate
53.23%
Net Income
Estimate
--2.70%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Ovid Therapeutics Inc.
Wall Street analysts predict an average 1-year price target for OVID of $7.33 , with forecasts ranging from
a
low of
$3 to a high of $11 .
OVID Lowest Price Target
Wall Street Target
3 USD
469.80%
OVID Average Price Target
Wall Street Target
7.33 USD
1292.85%
OVID Highest Price Target
Wall Street Target
11 USD
1989.27%
REVENUE FORECAST
Revenue Forecast Chart OVID
EBIT FORECAST
EBIT Forecast Chart OVID
NET INCOME FORECAST
Net Income Chart OVID